Related Experiment Video
Updated: Jul 2, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Synthesis of a multivalent, multiepitope vaccine construct.
1Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, USA.
This study presents an improved peptide synthesis strategy for creating complex protein mimics, specifically for influenza M2 protein-based vaccines. The new method facilitates the production of multiepitope and multivalent peptide constructs for therapeutic applications.
Area of Science:
- Peptide Chemistry
- Immunology
- Vaccine Design
Background:
- Reproducing complex protein active sites is a significant challenge in peptide chemistry.
- Therapeutic protein mimics often require multiple copies of active domains in specific spatial arrangements, such as subunit vaccines for ion-channel proteins.
Purpose of the Study:
- To describe an improved synthesis of a multiepitope and multivalent peptide construct based on the M2 protein of influenza virus.
- To provide a model synthetic strategy for preparing large, complex peptides or small engineered proteins.
Main Methods:
- Development of an improved synthesis for an M2-based multiepitope and multivalent peptide construct.
- Utilized an orthogonal N-terminal and side-chain-protecting scheme.
Main Results:
- An earlier construct with four copies of the M2 ectodomain and two T-helper cell epitopes induced protective antibody production in mice.
- The improved synthesis facilitates the creation of complex peptide constructs.
Conclusions:
- The described synthetic strategy can serve as a model for preparing large, complex peptides or small engineered proteins.
- This approach advances the design of peptide-based therapeutic agents and vaccine candidates.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cross-reactivity
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Vaccines